Benevolent Platform™
Applies AI and a proprietary knowledge graph to speed up biopharma drug discovery.
At a glance
Starts at
Free
No paid plan found on the vendor's site, September 2026.
Free tier
Yes
Platforms
Web
Best for
Biopharma companies and life science consultancies
Not for
Individual researchers outside a biopharma organization
3.9 out of 5
Scored by a Toolio reviewer after real useOur verdict
Benevolent Platform applies AI and machine learning, built on a decade-old proprietary knowledge graph and ontologies, to support biopharma drug discovery decisions. Its Qor product acts as an always-on strategic function for biopharma decision makers and life science consultancies. The site gives scientists and executives at those organizations a way to work with AI in their domain, but it isn't built for individual researchers, and pricing details aren't disclosed publicly.
✓What it does well
AI-driven drug discoveryIt applies AI and machine learning specifically to biopharma drug discovery work.
Proprietary knowledge graphA knowledge graph and proprietary ontologies built over a decade underpin the platform.
Qor strategic functionQor offers an always-on strategic function for biopharma decision makers and consultancies.
✕Where it falls short
Not for individual useThe platform is built for biopharma organizations, without a clear path for individual researchers.
Pricing not publicPricing and self-serve signup details are not disclosed on the site.
Narrow industry focusIt is narrow in scope, focused on biopharma and life sciences rather than broader research use.
Key features
AI drug discovery toolsIt applies AI and machine learning to biopharma drug discovery work.
Knowledge graph foundationA proprietary knowledge graph and ontologies support the platform's AI models.
Qor for decision makersQor provides an always-on strategic function for biopharma decision makers.
Life sciences consultancy supportIt supports life science consultancies alongside biopharma organizations directly.